Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 02 December 2011
The US Food and Drug Administration's (FDA) Center for Devices & Radiological Health (CDRH) has released selection of summary review memos of 180-day design changes to medical devices that have already won a green light from the federal watchdog agency. The memos detail applications to make substantial changes to already-approved medical devices. The federal watchdog agency's med-tech oversight arm said it began releasing the documents as part of the CDRH's transparency initiative. The 180-day supplements seek to make "a significant change in components, materials, design, specification, software, color additive, and labeling to an approved premarket application or premarket report," according to the agency. (Mass Device)
Tags: significant, Memo, 180-Day, PMA